JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

ResMed Inc

Închisă

SectorSănătate

222.12 1.1

Rezumat

Modificarea prețului

24h

Curent

Minim

219.17

Maxim

223.9

Indicatori cheie

By Trading Economics

Venit

44M

393M

Vânzări

87M

1.4B

P/E

Medie Sector

22.368

60.328

Randament dividend

0.99

Marjă de profit

27.593

Angajați

10,600

EBITDA

63M

566M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+29.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.99%

2.24%

Următoarele câștiguri

30 apr. 2026

Data viitoare de dividende

11 iun. 2026

Următoarea dată ex-dividende

7 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-4.3B

33B

Deschiderea anterioară

221.02

Închiderea anterioară

222.12

Sentimentul știrilor

By Acuity

10%

90%

12 / 348 Clasament în Healthcare

ResMed Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 apr. 2026, 23:15 UTC

Evenimente importante

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 apr. 2026, 23:08 UTC

Câștiguri
Principalele dinamici ale pieței

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 apr. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 apr. 2026, 22:10 UTC

Câștiguri

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 apr. 2026, 21:56 UTC

Câștiguri

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 apr. 2026, 21:44 UTC

Câștiguri

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 apr. 2026, 21:43 UTC

Câștiguri

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk
Evenimente importante

Basic Materials Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 apr. 2026, 20:39 UTC

Câștiguri

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparație

Modificare preț

ResMed Inc Așteptări

Obiectiv de preț

By TipRanks

29.86% sus

Prognoză pe 12 luni

Medie 285.5 USD  29.86%

Maxim 340 USD

Minim 255 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruResMed Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

8

Cumpărare

5

Păstrare

0

Vânzare

Sentiment

By Acuity

12 / 348 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat